Rayner Newsroom

Rayner proudly announced today that the registration of both the Sulcoflex Toric IOL and T-flex Aspheric Toric IOL system packs has been approved by the Korean Food and Drugs Administration (KFDA) and are now available for sale in the Republic of Korea.

Approval details

A review article by Jorge L. Alio and colleagues entitled “Enhancements after cataract surgery” discusses indications and outcomes following procedures to correct residual refractive error after cataract surgery, including use of the Sulcoflex^® lens.

The paper, published in Current Opinions in Ophthalmology, describes the main causes of unsatisfactory visual outcomes after cataract surgery and the current methods used to resolve suboptimal results. The authors note that although LASIK has proved to be the most accurate procedure to correct residual refractive error after cataract surgery...

Rayner today announces several changes to the senior management team. The appointments reflect renewed focus on Rayner’s surgical business following the divestment earlier last year of Rayner’s retail optometry business. The move will be complemented by a move later this year to The Ridley Innovation Centre, a brand new state-of-the art global headquarters and production facility in Worthing, West Sussex, UK. This major investment will enable Rayner to double its manufacturing capacity and support the company’s ambitious business expansion.

Rayner announced today that it had recently made an IOL donation to Orbis.
Orbis is an international charity which transpired through an alliance forged between the medical and aviation industries. Founded in 1982, the charity was developed to provide surgical knowledge and skills to doctors in developing countries through their unique Flying Eye Hospital and hospital-based training programmes.

A recent study by Talita Shimoda and colleagues entitled “Visual Outcomes after Implantation of a Novel Refractive Toric Multifocal Intraocular Lens”,  demonstrates the high efficacy of the M-flex T® multifocal toric IOL in achieving statistically significant visual acuity and refractive improvements as well as high spectacle independence in cataract patients. 

In a recent article in the Taiwan Journal of Ophthalmology, Dr Shao-Wei Weng and colleagues highlight the effectiveness and rotational stability of the T-flex^® Aspheric Toric lens.

This prospective study of 24 eyes in 24 patients demonstrated the predictable refractive outcomes that can be achieved with the T-flex^®, as 96% of patients had a corrected distance visual acuity (CDVA) of ≥20/40 post-operatively. This equated to a 6 Snellen line mean improvement in CDVA post-operatively compared to the pre-operative assessment.

Rayner Intraocular Lenses Limited today announces the launch of the company’s new injector, RaySert PLUS in the US market after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA).

RaySert® PLUS is designed for safe and effective implantation of the C-flex Aspheric IOL.
Simple and controlled IOL delivery through a wound assisted 2.2mm clear cornea mini incision.

The October 2014 Issue of the Journal of Cataract & Refractive Surgery (JCRS) presents a paper by Mr Vinod Gangwani, MRCOphth, FRCS, using the M-flex T and M-flex with Peripheral Corneal Relaxing Incisions (PCRIs) to correct astigmatism in patients requiring multi-focality.

This randomised, single blind study included patients with bilateral corneal astigmatism of between 1.0 and 2.5 Diopters and demonstrated the advantages of toric IOLs over PCRIs.

In the analysis of 58 eyes with 29 patients, the mean residual refractive astigmatism 3 months after surgery was 0.45 ± 0.49 D (maximum 1.50 D) 

The 2014 Rayner Medal Lecture was presented by Professor Harminder Dua at the Annual Meeting of the United Kingdom and Ireland Society of Cataract and Refractive Surgeons (UKISCRS).
Following his lecture: ‘the discovery of a new layer of the cornea; a pre-Descemet’s layer (Dua’s layer)’, Professor Dua was presented with the medal by Martin Jamieson, Chief Executive Officer at Rayner Intraocular Lenses Limited, and UKISCRS President Mr David O’Brart during the UKISCRS conference in London on September 14, 2014. 

ESCRS President Prof Bellucci, Amon, Osher, Alio, Arshinoff, Guell and Mrukwa- Kominek are just a few of the surgeons who ‘hopped on board’ Rayner’s double-decker bus at the XXIII ESCRS, to rediscover the rich history behind Harold Ridley and his invention that revolutionised ophthalmology.

With the 2014 ESCRS Congress being held in Rayner’s home country it was the perfect opportunity to do something special. Having manufactured the world’s first IOL in 1949,